Ibrutinib’s job is to fight off MCL, CLL, and Waldenström’s macroglobulinemia by targeting BTK. You’ll find it in either capsule or tablet form. The typical dose is between 420 and 560 mg, and you take it just once every day.
You can get the medication in bottles with 90 tablets each. By blocking BTK signaling, it messes with how cancer cells grow and hang around.
